DS-6157a
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DS-6157a, covering 2024-02-15 to 2024-02-15. Get the full timeline:
Most recent: Clinical Trial Update: DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST) [Phase 1]